Other Information
+Added: During the first quarter of 2024,
+Added: none of our directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule
+Added: 10b5-1 trading arrangement” (as each term is defined in Item 408(a) of Registration S-K).
Exhibit Number
6 unchanged sentences
Incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
+Added: Amendment No.
+Added: 1 to Financing Agreement, dated March 29, 2024.
+Added: Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 2, 2024.
Certification of Chief Executive Officer pursuant to 18 U.S.C.
13 unchanged sentences
OptimizeRx Corporation
−Removed: November 14, 2023
/s/ William J.
2 unchanged sentences
OptimizeRx Corporation
−Removed: November 14, 2023
/s/ Edward Stelmakh
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.